Trial Search Results

Experiences With Automated Surgical Drainage in Cardiac Surgery

The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Observations, experiences, and outcomes in a single hospital setting will be collected for the Thoraguard Surgical Drainage System.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Centese, Inc.

Collaborator: Stanford University

Stanford Investigator(s):


  • Device: Blood drainage post cardiac surgery


Inclusion Criteria:

   - Adult (age ≥ 18)

   - Patient undergoing non-emergent cardiac surgery

   - Anticipated requirement for mediastinal chest tube drainage

Exclusion Criteria:

   - Emergency surgery

   - Re-do surgery

   - Prior cardiac surgery

   - Congenital cardiac disease or deformation

   - Transplant surgery

   - Ventricular Assist Device Surgery

   - Suspected pulmonary air leak

   - Atrial fibrillation

   - In the opinion of the investigator the patient is unsuitable for the study for any
   other legitimate reason including incarceration, pre-existing medical or psychiatric
   condition, or interfering medications

   - Known previous or concurrent enrollment in a clinical trial that, in the opinion of
   the investigator, might interfere with the objectives of this clinical trial

   - Pregnancy

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305